Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.840
-0.010 (-0.54%)
Apr 29, 2026, 11:16 AM EDT - Market open
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $22.66 million as of April 29, 2026. Its market cap has decreased by -52.47% in one year.
Market Cap
22.66M
Enterprise Value
23.05M
1-Year Change
-52.47%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $22.66M, a decrease of -81.89%. That is a compound annual growth rate of -55.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 22.78M | 11.67% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AEON Biopharma | 24.91M |
| OSR Holdings | 24.65M |
| CEL-SCI | 24.60M |
| Tempest Therapeutics | 24.24M |
| Marker Therapeutics | 23.68M |
| Vistagen Therapeutics | 23.64M |
| Curis | 23.27M |
| Exicure | 22.12M |